Psychological intervention improves quality of life in patients with early-stage cancer: a systematic review and meta-analysis of randomized clinical trials.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 Jun 2024
Historique:
received: 03 10 2023
accepted: 29 05 2024
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 9 6 2024
Statut: epublish

Résumé

The effectiveness of psychological interventions (PI) for malignant diseases is controversial. We aimed to investigate the effect of PI on survival and quality of life (QoL) in patients with cancer. We performed a systematic search of MEDLINE, Cochrane, and Embase databases to identify randomized controlled trials comparing PI to standard care (PROSPERO registration number CRD42021282327). Outcomes were overall survival (OS), recurrence-free survival (RFS), and different domains of QoL. Subgroup analysis was performed based on the provider-, type-, environment-, duration of intervention; cancer stage, and type. Pooled hazard ratios (HR) and standardized mean difference (SMD) with 95% confidence intervals (CI) were calculated using a random-effects model. The OS and RFS did not differ significantly between the two groups (OS:HR = 0.97; CI 0.87-1.08; RFS:HR = 0.99; CI 0.84-1.16). However, there was significant improvement in the intervention group in all the analyzed domains of QoL; in the global (SMD = 0.65; CI 0.35-0.94), emotional (SMD = 0.64; CI 0.33-0.95), social (SMD = 0.32; CI 0.13-0.51) and physical (SMD = 0.33; CI 0.05-0.60) domains. The effect of PI on QoL was generally positive immediately, 12 and 24 weeks after intervention, but the effect decreased over time and was no longer found significant at 48 weeks. The results were better in the breast cancer group and early stages of cancer. PIs do not prolong survival, but they significantly improve the QoL of cancer patients. PI should be added as standard of care 3-4 times a year, at least for patients with early-stage cancer.

Identifiants

pubmed: 38853187
doi: 10.1038/s41598-024-63431-y
pii: 10.1038/s41598-024-63431-y
doi:

Types de publication

Journal Article Systematic Review Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

13233

Informations de copyright

© 2024. The Author(s).

Références

Bray, F., Laversanne, M., Weiderpass, E. & Soerjomataram, I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127, 3029–3030. https://doi.org/10.1002/cncr.33587 (2021).
doi: 10.1002/cncr.33587 pubmed: 34086348
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249. https://doi.org/10.3322/caac.21660 (2021).
doi: 10.3322/caac.21660 pubmed: 33538338
Dyba, T. et al. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur. J. Cancer 157, 308–347. https://doi.org/10.1016/j.ejca.2021.07.039 (2021).
doi: 10.1016/j.ejca.2021.07.039 pubmed: 34560371 pmcid: 8568058
Sosnowski, R. et al. Basic issues concerning health-related quality of life. Cent. Eur. J. Urol. 70, 206–211. https://doi.org/10.5173/ceju.2017.923 (2017).
doi: 10.5173/ceju.2017.923
Lewandowska, A. et al. Quality of life of cancer patients treated with chemotherapy. Int. J. Environ. Res. Public Health https://doi.org/10.3390/ijerph17196938 (2020).
doi: 10.3390/ijerph17196938 pubmed: 33374440 pmcid: 7795845
Lang-Rollin, I. & Berberich, G. Psycho-oncology. Dialogues Clin. Neurosci. 20, 13–22. https://doi.org/10.31887/DCNS.2018.20.1/ilangrollin (2018).
doi: 10.31887/DCNS.2018.20.1/ilangrollin pubmed: 29946207 pmcid: 6016045
Calver, L., Tickle, A., Moghaddam, N. & Biswas, S. The effect of psychological interventions on quality of life in patients with head and neck cancer: A systematic review and meta-analysis. Eur. J. Cancer Care. https://doi.org/10.1111/ecc.12789 (2018).
doi: 10.1111/ecc.12789
Ross, L., Boesen, E. H., Dalton, S. O. & Johansen, C. Mind and cancer: Does psychosocial intervention improve survival and psychological well-being?. Eur J Cancer 38, 1447–1457. https://doi.org/10.1016/s0959-8049(02)00126-0 (2002).
doi: 10.1016/s0959-8049(02)00126-0 pubmed: 12110489
D’Egidio, V. et al. Counseling interventions delivered in women with breast cancer to improve health-related quality of life: A systematic review. Qual. Life Res. 26, 2573–2592. https://doi.org/10.1007/s11136-017-1613-6 (2017).
doi: 10.1007/s11136-017-1613-6 pubmed: 28623442
McLachlan, S. A. et al. Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. J. Clin. Oncol. 19, 4117–4125. https://doi.org/10.1200/JCO.2001.19.21.4117 (2001).
doi: 10.1200/JCO.2001.19.21.4117 pubmed: 11689579
Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J. Clin. Epidemiol. 62, e1-34. https://doi.org/10.1016/j.jclinepi.2009.06.006 (2009).
doi: 10.1016/j.jclinepi.2009.06.006 pubmed: 19631507
Chandler, J. & Hopewell, S. Cochrane methods–twenty years experience in developing systematic review methods. Syst. Rev. 2, 76. https://doi.org/10.1186/2046-4053-2-76 (2013).
doi: 10.1186/2046-4053-2-76 pubmed: 24050381 pmcid: 3849105
Hedges, L. V. Distribution theory for glass’s estimator of effect size and related estimators. J. Educ. Stat. 6, 107–128. https://doi.org/10.2307/1164588 (1981).
doi: 10.2307/1164588
Team, R. C. A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2022).
Viechtbauer, W. Metafor: Meta-Analysis Package for r, https://cran.r-project.org/package=metafor (2022).
Schwarzer, G. Meta: General Package for Meta-Analysis, https://doi.org/10.1007/978-3-319-21416-0 (2022).
Wickham, H. et al. Ggplot2: Create Elegant Data Visualisations Using the Grammar of Graphics. https://cran.r-project.org/package=ggplot2 (2022).
Sterne, J. A. C. et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343, d4002. https://doi.org/10.1136/bmj.d4002 (2011).
doi: 10.1136/bmj.d4002 pubmed: 21784880
Bjorneklett, H. G. et al. A randomised controlled trial of support group intervention after breast cancer treatment: Results on anxiety and depression. Acta Oncol. 51, 198–207. https://doi.org/10.3109/0284186X.2011.610352 (2012).
doi: 10.3109/0284186X.2011.610352 pubmed: 21923569
Carbajal-Lopez, E. B., Juarez-Garcia, D. M., Espinoza-Velazco, A. & Calderillo-Ruiz, G. Internet-delivered cognitive behavioral therapy and psychoeducation program for patients with gastrointestinal stromal tumors. J. Cancer Educ. 37, 668–674. https://doi.org/10.1007/s13187-020-01866-3 (2022).
doi: 10.1007/s13187-020-01866-3 pubmed: 32894418
Rahmani, S., Talepasand, S. & Ghanbary-Motlagh, A. Comparison of effectiveness of the metacognition treatment and the mindfulness-based stress reduction treatment on global and specific life quality of women with breast cancer. Iran J. Cancer Prev. 7, 184–196 (2014).
pubmed: 25628839 pmcid: 4307101
Lapid, M. I. et al. Improving the quality of life of geriatric cancer patients with a structured multidisciplinary intervention: A randomized controlled trial. Palliat. Support Care 5, 107–114. https://doi.org/10.1017/s1478951507070174 (2007).
doi: 10.1017/s1478951507070174 pubmed: 17578061
Lu, J. et al. Effectiveness of an intervention to promote self-efficacy on quality of life of patients with nasopharyngeal carcinoma of the zhuang tribe minority in Guangxi, China: A prospective study. Med. Sci. Monit. 23, 4077–4086. https://doi.org/10.12659/msm.903205 (2017).
doi: 10.12659/msm.903205 pubmed: 28832557 pmcid: 5578692
Murphy, M. J. et al. Randomised controlled trial of internet-delivered cognitive behaviour therapy for clinical depression and/or anxiety in cancer survivors (iCanADAPT Early). Psychooncology 29, 76–85. https://doi.org/10.1002/pon.5267 (2020).
doi: 10.1002/pon.5267 pubmed: 31659822
Pettiford, J. et al. A bio-psychosocial intervention program for improving quality of life in breast cancer survivors—final outcome of a prospective randomized trial. Breast J. 23, 537–544. https://doi.org/10.1111/tbj.12786 (2017).
doi: 10.1111/tbj.12786 pubmed: 28233921
Poort, H. et al. Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: A randomized controlled trial. Ann. Oncol. 31, 115–122. https://doi.org/10.1016/j.annonc.2019.09.002 (2020).
doi: 10.1016/j.annonc.2019.09.002 pubmed: 31912784
Sharpe, M. et al. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): A multicentre randomised controlled effectiveness trial. Lancet 384, 1099–1108. https://doi.org/10.1016/S0140-6736(14)61231-9 (2014).
doi: 10.1016/S0140-6736(14)61231-9 pubmed: 25175478
Borosund, E. et al. Results from a randomized controlled trial testing StressProffen; An application-based stress-management intervention for cancer survivors. Cancer Med. 9, 3775–3785. https://doi.org/10.1002/cam4.3000 (2020).
doi: 10.1002/cam4.3000 pubmed: 32243717 pmcid: 7286452
Ell, K. et al. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J. Clin. Oncol. 26, 4488–4496. https://doi.org/10.1200/JCO.2008.16.6371 (2008).
doi: 10.1200/JCO.2008.16.6371 pubmed: 18802161 pmcid: 2653113
Izci, F., Ilgun, A. S., Findikli, E. & Ozmen, V. Psychiatric symptoms and psychosocial problems in patients with breast cancer. J. Breast Health 12, 94–101. https://doi.org/10.5152/tjbh.2016.3041 (2016).
doi: 10.5152/tjbh.2016.3041 pubmed: 28331743 pmcid: 5351486
Akechi, T., Okuyama, T., Onishi, J., Morita, T. & Furukawa, T. A. Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst. Rev. 2008, CD005537. https://doi.org/10.1002/14651858.CD005537.pub2 (2008).
doi: 10.1002/14651858.CD005537.pub2 pubmed: 18425922 pmcid: 6464138
Montazeri, A. Quality of life data as prognostic indicators of survival in cancer patients: An overview of the literature from 1982 to 2008. Health Qual. Life Outcomes 7, 102. https://doi.org/10.1186/1477-7525-7-102 (2009).
doi: 10.1186/1477-7525-7-102 pubmed: 20030832 pmcid: 2805623
Firkins, J., Hansen, L., Driessnack, M. & Dieckmann, N. Quality of life in “chronic” cancer survivors: A meta-analysis. J. Cancer Surviv. 14, 504–517. https://doi.org/10.1007/s11764-020-00869-9 (2020).
doi: 10.1007/s11764-020-00869-9 pubmed: 32162194
Shapiro, C. J., Watson MacDonell, K. & Moran, M. Provider self-efficacy in delivering evidence-based psychosocial interventions: A scoping review. Implement. Res. Pract. 2, 2633489520988258. https://doi.org/10.1177/2633489520988258 (2021).
doi: 10.1177/2633489520988258 pubmed: 37089984 pmcid: 9978642
Sogomonjan, M., Kerikmäe, T. & Ööpik, P. A review article on internet-based psychological interventions in primary care. What is the global experience? How reliable are results from RCTs? Lessons learned from the European, US and Australian case studies. TalTech J. Eur. Stud. 8, 145–163. https://doi.org/10.1515/bjes-2018-0019 (2018).
doi: 10.1515/bjes-2018-0019
Shechtman, Z. & Kiezel, A. Why do people prefer individual therapy over group therapy?. Int. J. Group Psychother. 66, 571–591. https://doi.org/10.1080/00207284.2016.1180042 (2016).
doi: 10.1080/00207284.2016.1180042 pubmed: 38475636
Blickle, P., Schmidt, M. E. & Steindorf, K. Post-traumatic growth in cancer survivors: What is its extent and what are important determinants?. Int. J. Clin. Health Psychol. 24, 100418. https://doi.org/10.1016/j.ijchp.2023.100418 (2024).
doi: 10.1016/j.ijchp.2023.100418 pubmed: 37867603
Nam, S. K. et al. A meta-analysis of gender differences in attitudes toward seeking professional psychological help. J. Am. Coll. Health 59, 110–116. https://doi.org/10.1080/07448481.2010.483714 (2010).
doi: 10.1080/07448481.2010.483714 pubmed: 20864437
Liddon, L., Kingerlee, R. & Barry, J. A. Gender differences in preferences for psychological treatment, coping strategies, and triggers to help-seeking. Br. J. Clin. Psychol. 57, 42–58. https://doi.org/10.1111/bjc.12147 (2018).
doi: 10.1111/bjc.12147 pubmed: 28691375
Evans, L. J., Beck, A. & Burdett, M. The effect of length, duration, and intensity of psychological therapy on CORE global distress scores. Psychol. Psychother. Theory Res. Pract. 90, 389–400. https://doi.org/10.1111/papt.12120 (2017).
doi: 10.1111/papt.12120
Hegyi, P., Eross, B., Izbeki, F., Parniczky, A. & Szentesi, A. Accelerating the translational medicine cycle: The Academia Europaea pilot. Nat. Med. 27, 1317–1319. https://doi.org/10.1038/s41591-021-01458-8 (2021).
doi: 10.1038/s41591-021-01458-8 pubmed: 34312557
Hegyi, P. et al. Academia Europaea position paper on translational medicine: The cycle model for translating scientific results into community benefits. J. Clin. Med. https://doi.org/10.3390/jcm9051532 (2020).
doi: 10.3390/jcm9051532 pubmed: 32987707 pmcid: 7598585

Auteurs

Sára Anna Bognár (SA)

Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary.
Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.

Brigitta Teutsch (B)

Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.
Institute for Translational Medicine, Medical School, University of Pécs, 7623, Pecs, Hungary.

Stefania Bunduc (S)

Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.

Dániel Sándor Veres (DS)

Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.
Department of Biophysics and Radiation Biology, Semmelweis University, 1085, Budapest, Hungary.

Bence Szabó (B)

Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.

Beatrix Fogarasi (B)

Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary.

Olga Júlia Zahariev (OJ)

Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary.
Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.

Nóra Vörhendi (N)

Institute for Translational Medicine, Medical School, University of Pécs, 7623, Pecs, Hungary.
Department of Internal Medicine, Siófok City Hospital and Outpatient Clinic, 8601, Siófok, Hungary.

Omer Almog (O)

Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.

Yael Hadani (Y)

Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.

Dorottya Gergő (D)

Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.
Department of Pharmacognosy, Semmelweis University, Üllői út 26, 1085, Budapest, Hungary.

Emese Mihály (E)

Department of Internal Medicine and Hematology, Medical School, Semmelweis University, 1088, Budapest, Hungary.

Bálint Erőss (B)

Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary.
Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.
Institute for Translational Medicine, Medical School, University of Pécs, 7623, Pecs, Hungary.

Stefania Bunduc (S)

Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.
Center for Digestive Diseases and Liver Transplant, Fundeni Clinical Institute, 022328, Bucharest, Romania.

Katalin Márta (K)

Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary.
Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.
Translational Pancreatology Research Group, Interdisciplinary Centre of Excellence for Research Development and Innovation University of Szeged, 6725, Szeged, Hungary.

Péter Hegyi (P)

Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary. hegyi2009@gmail.com.
Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary. hegyi2009@gmail.com.
Institute for Translational Medicine, Medical School, University of Pécs, 7623, Pecs, Hungary. hegyi2009@gmail.com.
Translational Pancreatology Research Group, Interdisciplinary Centre of Excellence for Research Development and Innovation University of Szeged, 6725, Szeged, Hungary. hegyi2009@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH